Ontology highlight
ABSTRACT:
SUBMITTER: Stacchiotti S
PROVIDER: S-EPMC5452071 | biostudies-literature | 2017 Jun
REPOSITORIES: biostudies-literature
Stacchiotti S S Gronchi A A Fossati P P Akiyama T T Alapetite C C Baumann M M Blay J Y JY Bolle S S Boriani S S Bruzzi P P Capanna R R Caraceni A A Casadei R R Colia V V Debus J J Delaney T T Desai A A Dileo P P Dijkstra S S Doglietto F F Doglietto F F Flanagan A A Froelich S S Gardner P A PA Gelderblom H H Gokaslan Z L ZL Haas R R Heery C C Hindi N N Hohenberger P P Hornicek F F Imai R R Jeys L L Jones R L RL Kasper B B Kawai A A Krengli M M Leithner A A Logowska I I Martin Broto J J Mazzatenta D D Morosi C C Nicolai P P Norum O J OJ Patel S S Penel N N Picci P P Pilotti S S Radaelli S S Ricchini F F Rutkowski P P Scheipl S S Sen C C Tamborini E E Thornton K A KA Timmermann B B Torri V V Tunn P U PU Uhl M M Yamada Y Y Weber D C DC Vanel D D Varga P P PP Vleggeert-Lankamp C L A CLA Casali P G PG Sommer J J
Annals of oncology : official journal of the European Society for Medical Oncology 20170601 6
Chordomas are rare, malignant bone tumors of the skull-base and axial skeleton. Until recently, there was no consensus among experts regarding appropriate clinical management of chordoma, resulting in inconsistent care and suboptimal outcomes for many patients. To address this shortcoming, the European Society of Medical Oncology (ESMO) and the Chordoma Foundation, the global chordoma patient advocacy group, convened a multi-disciplinary group of chordoma specialists to define by consensus evide ...[more]